Streetbeat News

Price Targets

HUN

B of A Securities analyst Steve Byrne has upgraded Huntsman (NYSE:HUN) from Underperform to Buy and set a price target of $27.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:08 pm

CMG

CTV

ESTC

MA

NKTX

NVDA

SBSW

TMO

V

WEN

Top Wall Street analysts have updated their outlooks on several stocks. Raymond James cut Chipotle's price target from $2,300 to $2,100 and Wedbush slashed Wendy's price target from $26.5 to $24. Keybanc raised Visa's price target from $265 to $275 and increased Mastercard's price target from $435 to $440. Jefferies increased Elastic's price target from $75 to $100. RBC Capital cut Sibanye Stillwater's price target from $9 to $6.5. Needham cut Innovid's price target from $3 to $1.5. Raymond James slashed Thermo Fisher Scientific's price target from $630 to $580. HC Wainwright & Co. lowered Nkarta's price target from $16 to $10. Citigroup slashed NVIDIA's price target from $630 to $575.

Portfolio Pulse from Lisa Levin

October 18, 2023 | 12:04 pm

LYB

B of A Securities analyst Steve Byrne has upgraded LyondellBasell Industries (NYSE:LYB) from Underperform to Neutral and raised the price target from $99 to $107.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:02 pm

BRZE

Over the past 3 months, 21 analysts have published their opinion on Braze (NASDAQ:BRZE) stock. The company has an average price target of $53.62 with a high of $65.00 and a low of $35.00. This average price target has increased by 18.42% over the past month.

Portfolio Pulse from Benzinga Insights

October 18, 2023 | 12:00 pm

DOW

B of A Securities analyst Steve Byrne has upgraded Dow (NYSE:DOW) from Underperform to Neutral and raised the price target from $55 to $59.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 11:59 am

NVDA

Citigroup analyst Atif Malik has maintained a 'Buy' rating on NVIDIA, but lowered the price target from $630 to $575.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 11:56 am

HOLX

Raymond James analyst Andrew Cooper maintains an 'Outperform' rating on Hologic (NASDAQ:HOLX), but has lowered the price target from $95 to $85.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 11:52 am

TMO

Raymond James analyst Andrew Cooper maintains an Outperform rating on Thermo Fisher Scientific (NYSE:TMO) but has lowered the price target from $630 to $580.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 11:50 am

RVTY

Raymond James analyst Andrew Cooper has maintained an Outperform rating on Revvity (NYSE:RVTY), but lowered the price target from $145 to $135.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 11:48 am

NKTX

HC Wainwright & Co. analyst Emily Bodnar maintains a 'Buy' rating on Nkarta (NASDAQ:NKTX) but lowers the price target from $16 to $10.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 11:47 am